HomeO6Z • SGX
add
Lonza Group AG
Nakaraang pagsara
$79.97
Sakop ng taon
$65.00 - $80.16
Market cap
42.04B CHF
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CHF) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.53B | -0.68% |
Gastos sa pagpapatakbo | 282.50M | 10.78% |
Net na kita | 164.50M | -19.76% |
Net profit margin | 10.76 | -19.22% |
Kita sa bawat share | — | — |
EBITDA | 412.00M | -8.34% |
Aktuwal na % ng binabayarang buwis | 16.46% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CHF) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.02B | -6.10% |
Kabuuang asset | 17.88B | 1.20% |
Kabuuang sagutin | 8.47B | 16.00% |
Kabuuang equity | 9.41B | — |
Natitirang share | 71.37M | — |
Presyo para makapag-book | 0.61 | — |
Return on assets | 3.85% | — |
Return on capital | 5.21% | — |
Cash Flow
Net change in cash
| (CHF) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 164.50M | -19.76% |
Cash mula sa mga operasyon | 252.50M | 36.86% |
Cash mula sa pag-invest | -527.50M | -141.97% |
Cash mula sa financing | 237.00M | 10.23% |
Net change in cash | -35.50M | -119.78% |
Malayang cash flow | -182.56M | 12.81% |
Tungkol
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
Itinatag
1897
Headquarters
Website
Mga Empleyado
18,686
